164 related articles for article (PubMed ID: 24321721)
1. Oxidative stress-associated neuroretinal dysfunction and nitrosative stress in diabetic retinopathy.
Mandal LK; Choudhuri S; Dutta D; Mitra B; Kundu S; Chowdhury IH; Sen A; Chatterjee M; Bhattacharya B
Can J Diabetes; 2013 Dec; 37(6):401-7. PubMed ID: 24321721
[TBL] [Abstract][Full Text] [Related]
2. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
4. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
6. Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
Jiang H; Du J; He T; Qu J; Song Z; Wu S
Clin Exp Ophthalmol; 2014 Dec; 42(9):841-5. PubMed ID: 24645972
[TBL] [Abstract][Full Text] [Related]
7. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers.
Mohammad G; Alam K; Nawaz MI; Siddiquei MM; Mousa A; Abu El-Asrar AM
J Physiol Biochem; 2015 Sep; 71(3):359-72. PubMed ID: 26040511
[TBL] [Abstract][Full Text] [Related]
8. Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy.
Asadova V; Gul Z; Buyukuysal RL; Yalcinbayir O
Int Ophthalmol; 2020 Jan; 40(1):227-234. PubMed ID: 31571092
[TBL] [Abstract][Full Text] [Related]
9. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Suzuki Y; Yao T; Okumura K; Seko Y; Kitano S
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1519-1525. PubMed ID: 31062144
[TBL] [Abstract][Full Text] [Related]
10. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
11. Aqueous Humour and Serum Levels of Nitric Oxide, Malondialdehyde and Total Antioxidant Status in Patients with Type 2 Diabetes with Proliferative Diabetic Retinopathy and Nondiabetic Senile Cataracts.
Kulaksızoglu S; Karalezli A
Can J Diabetes; 2016 Apr; 40(2):115-9. PubMed ID: 26388409
[TBL] [Abstract][Full Text] [Related]
12. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
16. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
17. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
18. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
